| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.2 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |